ATE535601T1 - Züchtung von fremdtransplantationsmaterial in kultur - Google Patents

Züchtung von fremdtransplantationsmaterial in kultur

Info

Publication number
ATE535601T1
ATE535601T1 AT02799523T AT02799523T ATE535601T1 AT E535601 T1 ATE535601 T1 AT E535601T1 AT 02799523 T AT02799523 T AT 02799523T AT 02799523 T AT02799523 T AT 02799523T AT E535601 T1 ATE535601 T1 AT E535601T1
Authority
AT
Austria
Prior art keywords
sgs
index
culture
islets
breeding
Prior art date
Application number
AT02799523T
Other languages
English (en)
Inventor
Olga Garkavenko
Original Assignee
Diabcell Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diabcell Pty Ltd filed Critical Diabcell Pty Ltd
Application granted granted Critical
Publication of ATE535601T1 publication Critical patent/ATE535601T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0683—Cells of the male genital tract, e.g. prostate, epididymis; Non-germinal cells from testis, e.g. Leydig cells, Sertoli cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/22—Coculture with; Conditioned medium produced by pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/246—Cells of the male genital tract, non-germinal testis cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Mushroom Cultivation (AREA)
  • Materials For Medical Uses (AREA)
AT02799523T 2001-09-28 2002-09-27 Züchtung von fremdtransplantationsmaterial in kultur ATE535601T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ51454601 2001-09-28
PCT/NZ2002/000197 WO2003027270A1 (en) 2001-09-28 2002-09-27 Growing xenotransplant material in culture

Publications (1)

Publication Number Publication Date
ATE535601T1 true ATE535601T1 (de) 2011-12-15

Family

ID=19928768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02799523T ATE535601T1 (de) 2001-09-28 2002-09-27 Züchtung von fremdtransplantationsmaterial in kultur

Country Status (4)

Country Link
US (1) US20050042746A1 (de)
EP (1) EP1438395B1 (de)
AT (1) ATE535601T1 (de)
WO (1) WO2003027270A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
US20090047325A1 (en) * 1999-04-30 2009-02-19 Neurotrophincell Pty. Limited Xenotransplant for cns therapy
US20050265977A1 (en) * 1999-04-30 2005-12-01 Elliott Robert B Xenotransplant for CNS therapy
DE60044431D1 (en) * 1999-04-30 2010-07-01 Neurotrophincell Pty Ltd Xenotransplant für zns therapie
DK1248640T3 (da) 2000-01-20 2007-02-12 Diabcell Pty Ltd Xenotransplantation af svineöer og deres fremstilling
EP1636346A4 (de) * 2003-06-24 2007-03-28 Diabcell Pty Ltd Mit sertolizellen aus schwein kultivierte inselzellen aus schwein zur xenotransplantation
EP1648380B1 (de) * 2003-07-03 2015-04-08 Sertoli Technologies, LLC Zusammensetzungen mit sertoli-zellen und myoid-zellen und ihre verwendung in zellulären transplanten
NZ539491A (en) 2005-04-15 2008-04-30 Living Cell Products Pty Ltd Swine population and uses thereof
NZ536009A (en) * 2005-04-18 2007-01-26 Neurotrophincell Pty Ltd Choroid plexus preparation and uses thereof
NZ540597A (en) * 2005-06-08 2007-02-23 Neurotrophincell Pty Ltd A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells
US20090090214A1 (en) * 2007-10-04 2009-04-09 Chung Yuan Christian University Method for forming nano-scale metal particles
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4850993A (en) * 1986-12-22 1989-07-25 Miles Laboratories, Inc. Blood bag system incorporating quinolone carboxylic, acid derivatives
US5871472A (en) * 1987-11-17 1999-02-16 Brown University Research Foundation Planting devices for the focal release of neuroinhibitory compounds
US5283187A (en) * 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5650148A (en) * 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
SG47470A1 (en) * 1991-04-25 1998-04-17 Univ Brown Res Found Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products
CA2159738A1 (en) * 1993-04-13 1994-10-27 Eugene O. Major Use of neuro-derived fetal cell lines for transplantation therapy
US6090400A (en) * 1994-02-07 2000-07-18 The Trustees Of The Childhood Diabetes Transplant Research Trust Pharmaceutical preparation and method for treatment of diabetes
US5958404A (en) * 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
AU715177B2 (en) * 1994-04-13 2000-01-20 Research Corporation Technologies, Inc. Methods of treating disease using sertoli cells and allografts or xenografts
US5849285A (en) * 1994-04-13 1998-12-15 Research Corporation Technologies, Inc. Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells
US5550050A (en) * 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
US6001647A (en) * 1994-04-28 1999-12-14 Ixion Biotechnology, Inc. In vitro growth of functional islets of Langerhans and in vivo uses thereof
US5587309A (en) * 1994-04-29 1996-12-24 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating proliferation and differentiation of human fetal pancreatic cells ex vivo
US5898066A (en) * 1994-08-26 1999-04-27 Children's Medical Center Corporation Trophic factors for central nervous system regeneration
US5853385A (en) * 1994-08-26 1998-12-29 Cytotherapeutics, Inc. Encapsulated PC12 cell transplants for treatment of Parkinson's disease
AU7443996A (en) * 1995-10-30 1997-05-22 Vivorx, Inc. Method for ex vivo proliferation and differentiation of adult pancreatic islet cells, media useful therefor and uses thereof
CA2179341A1 (en) * 1996-04-12 1997-10-13 Gregory S. Korbutt Methods for isolating, enriching and increasing the maturation of cells
US6001643A (en) * 1997-08-04 1999-12-14 C-Med Inc. Controlled hydrodynamic cell culture environment for three dimensional tissue growth
US5968829A (en) * 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6432710B1 (en) * 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
PL191994B1 (pl) * 1998-12-15 2006-08-31 Univ Mexico Nacional Autonoma Sposób i urządzenie do wspomagania implantowania materiału biologicznego
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
AU1112202A (en) * 2000-10-17 2002-04-29 Diatranz Ltd Preparation and xenotransplantation or porcine islets
WO2002094987A2 (en) * 2001-05-18 2002-11-28 Cornell Research Foundation, Inc. In vitro production of haploid germ cells

Also Published As

Publication number Publication date
EP1438395A1 (de) 2004-07-21
EP1438395B1 (de) 2011-11-30
EP1438395A4 (de) 2006-04-12
HK1067151A1 (en) 2005-04-01
US20050042746A1 (en) 2005-02-24
WO2003027270A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
Takaku et al. In vivo cell tracking by bioluminescence imaging after transplantation of bioengineered cell sheets to the knee joint
ATE270323T1 (de) Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo
CN105112362B (zh) 一种胎盘间充质干细胞的无血清培养基及其制备方法
KR20040045856A (ko) 상처 치료용 생물학적 활성 물질로서 사용될 수 있는각질세포
CN101757690A (zh) 一种制备组织工程角膜的方法
EP2180043A1 (de) Verfahren zur Unterscheidung von menschlichen erwachsenen Stammzellen in insulinabgebende Zellen
Saxena Tissue engineering: Present concepts and strategies
Higa et al. Recent advances in cultivated epithelial transplantation
CN109112101A (zh) 一种成纤维细胞培养基及其应用
CN102807965A (zh) 一种组织工程角膜的制备方法及其装置
CN103695367B (zh) 一种改良的新生猪胰岛细胞培养基及其使用方法
CN106047793B (zh) 一种皮肤角质形成细胞的培养基及其培养方法
CN101138653B (zh) 一种含脂肪层的组织工程皮肤及其制备方法
KR20010072553A (ko) 살아있는 키메릭 피부 대체물
CN109402049B (zh) 一种可用于软骨损伤修复的具有软骨分化潜能的组织工程脂肪干细胞片层的制备方法
Mohammad-Pour et al. Comparing the effects of two cryoprotectant protocols, dimethyl-sulfoxide (DMSO) and glycerol, on the recovery rate of cultured keratinocytes on amniotic membrane
CN105963795A (zh) 一种基于胶原制备组织工程表皮的方法
EP1438395A4 (de) Züchtung von fremdtransplantationsmaterial in kultur
CN1865436B (zh) 一种分离纯化皮肤表皮干细胞的方法
CN1321704C (zh) 采用生物反应器制备双层活性人工皮肤组织的方法
CA2320423A1 (en) Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies
Viravaidya-Pasuwat et al. Construction of a chondrocyte cell sheet using temperature-responsive poly (N-isopropylacrylamide)-co-acrylamide
CN105087466A (zh) 诱导脐带间充质干细胞向角膜上皮细胞分化的培养基和方法
US20100015198A1 (en) Transplants encapsulated with self-elastic cartilage and method of preparing the same
Proulx et al. Stem cells of the skin and cornea: their clinical applications in regenerative medicine